Pharma Pulse: AstraZeneca-BMS Speculation Cools, Drones Land in Pharmacy, Agentic AI Hits 3PL – Pharmaceutical Commerce

Pharmaceutical Commerce reports on three developments affecting the industry: speculation regarding a potential merger between AstraZeneca and Bristol Myers Squibb has diminished, drone technology is being deployed in pharmacy operations, and agentic artificial intelligence is being implemented in third-party logistics. The report suggests these trends reflect evolving market conditions and technological adoption across pharmaceutical supply chains and distribution.

Read Full Article →